News

Immunomedics has reported results that indicate CD74 is expressed at high levels in the majority of gastrointestinal tumors, which may allow milatuzumab, the company’s humanized anti-CD74 antibody, to

Antiviral activity was observed at all dose levels tested either as single agent or in combination with ribavirin. Treatment was well-tolerated with reversible, dose-dependent increases in liver enzyme

In this 15-day study, SCY-635 was well-tolerated with no serious adverse events, no discontinuations and no dose-limiting toxicities. At the highest dose tested in the study (900mg/day) SCY-635

Mr Mitchell is chairman of the board and CEO of Arrow Electronics, a provider of products, services and solutions to industrial and commercial users of electronic components and

Poniard Pharmaceuticals has reported encouraging data from a Phase I dose-escalation study of picoplatin in patients with metastatic colorectal cancer. Results demonstrated that picoplatin can be safely administered

Genesis Pharmaceuticals Enterprises, a US-based pharmaceutical company with its principal operations in China, has launched three traditional Chinese medicines. The traditional Chinese medicines (TCMs) are Yi Mu Cao

The measures are expected to generate increased operational efficiencies and reduce costs while continuing to allow Sequenom to serve the needs of its current and future genetic analysis

The trial was sponsored by the National Cancer Institute (NCI) and led by the Eastern Cooperative Oncology Group under a clinical trials agreement between NCI and Bayer and

According to the company, the job cuts are expected to be completed by June 22, 2009. Arena believes that job reduction is necessary to reduce its cash usage